medigraphic.com
ISSN 2221-2434 (Electronic)

2015, Number 2

<< Back Next >>

Finlay 2015; 5 (2)

Severe preeclampsia: characteristics and consequences

Pérez VAÁA, Prieto CE, Hernández PRM

Language: Spanish
References: 33
Page: 118-129
PDF size: 391.33 Kb.


ABSTRACT

Background: preeclampsia is a hypertensive disorder of pregnancy and a major cause of perinatal and maternal morbidity and mortality.
Objective: to identify maternal and therapeutic factors as well as damage associated with severe preeclampsia in pregnant women.
Method: a case series study was conducted in 69 patients diagnosed with severe preeclampsia treated at the Dr. Gustavo Aldereguía Lima University General Hospital from January 1, 2012 through December 31, 2013. They were divided into two groups according to presence of severe preeclampsia with and without aggravating factors. The variables analyzed were related to maternal characteristics, characteristics of medical care and fetal and neonatal characteristics. A questionnaire based on the data obtained from medical records was applied in line with the International Classification of Diseases, Tenth Revision. Comparisons between groups were performed using a chi-square statistic, considering a P‹0.05 statically significant.
Results: frequency of severe preeclampsia was 0.8 per 100 deliveries. The highest frequency occurred in the age range of 31-35 years. Eclampsia was observed in 0.91 per 1000 deliveries. Maternal damage amounted to 30.4%. Magnesium sulfate prophylaxis was used in 89% of cases. Eclampsia frequency when not used was 50%, while it was only 6.4% when this therapy was applied. Caesarean section was performed in 85.5% of patients. Neonatal damage was 52.3%. The late fetal death rate was 4.6 per 100 live births. Among the intergroup differences, significant dissimilarities were observed in neonatal damage.
Conclusion: high association of intrauterine growth restriction with induced prematurity is evident as well as the high rate of first-time Caesarean sections and significant maternal, fetal and neonatal damage. The use of magnesium sulfate shows good results in the prophylaxis of eclampsia.


REFERENCES

  1. Steegers E, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010 ; 376 (9741): 63-44.

  2. García R, Llera A, Pacheco AL, Delgado MJ, González A. Resultados maternos-perinatales de pacientes con preeclampsia. Rev Cubana Obstet Ginecol [revista en Internet]. 2012 [ cited 2 Feb 2015 ] ; 38 (4): [aprox. 11p]. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S0138-600X2012000400004&lng=es&nrm=i so&tlng=es.

  3. Choia SY, Yun J, Lee OJ, Han HS, Yeo MK, Lee MA, et al. MicroRNA expression profiles in placenta with severe preeclampsia using a PNA-based microarray. Placenta. 2013 ; 34 (9): 799-804.

  4. Chen DB, Wang W. Human placental microRNAs and preeclampsia. Biol Reprod. 2013 ; 88 (5): 130.

  5. Enquobahrie DA, Abetew DF, Sorensen TK, Willoughby D, Chidambaram K, Williams MA. Placental microRNA expression in pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 2011 ; 204 (2): 12-21.

  6. Ouyang Y, Mouillet JF, Coyne CB, Sadovsky Y. Review: placenta-specific microRNAs in exosomes–good things come in nano-packages. Placenta. 2014 ; 35 (Suppl): S69-S73.

  7. Organización Panamericana de la salud. La salud y los Objetivos de Desarrollo del Milenio: del compromiso a la acción [Internet]. Washington: Organización Panamericana de la Salud; 2011. [ cited 3 Ene 2015 ] Available from: http://www.paho.org/pan/index.php?option=com_ content&view=article&id=378:la-salud-objetivosdesarrollo-milenio-compromiso-accion-&Itemid=0.

  8. Ministerio de Salud Pública. Anuario Estadístico de Salud 2011 [Internet]. La Habana: Dirección Nacional de Estadísticas; 2012. [ cited Sep 2014 ] Available from: http://files.sld.cu/bvscuba/files/2012/05/anuario-2 011-e.pdf.

  9. Rasmussen S, Irgens LM. History of fetal growth restriction is more strongly associated with severe rather than milder pregnancy-induced hypertension. Hypertension. 2008 ; 51 (4): 1231-8.

  10. Kochanek KD, Kirmeyer SE, Martin JA, Strobino DM, Guyer B. Annual summary of vital statistics: 2009. Pediatrics. 2012 ; 129 (2): 338-48.

  11. Vogel JP, Souza JP, Mori R, Morisaki N, Lumbiganon P, Laopaiboon M, et al. Maternal complications and perinatal mortality: findings of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014 ; 121 Suppl 1: S76-88.

  12. King JC. Maternal mortality in the United States - why is it important and what are we doing about it?. Semin Perinatol. 2012 ; 36 (1): 14-8.

  13. Cunninghan F, Steven L. Williams Obstetricia. 23a ed. Ciudad Mexico: McGraw-Hill; 2010.

  14. Amaral WT Peraçoli JC. Fatores de risco relacionados à pré-eclâmpsia. Comun ciênc saúde. ; 22 Suppl esp. 1: S153-160.

  15. Águila S, Hernández E, Breto A, Cabezas E, Hernández E, Delgado JJ, et al. Obstetricia y Perinatología. Diagnóstico y tratamiento. La Habana: ECIMED; 2012.

  16. Schwarcs RL, Fescina R, Diverges C. Obstetricia. 6ta. ed. Buenos Aires: El Ateneo; 2007.

  17. Lovesio C. Medicina Intensiva. Materna Grave. Enfermedad Hipertensiva del embarazo. Buenos Aires: El Ateneo; 2008.

  18. Clark MD. Strategies for reducing maternal mortality. Semin Perinatol. 2012 ; 36 (1): 42-7.

  19. National Collaborating Centre for Women´s and Children´s Health (UK). Hypertension in pregnancy: The management of hypertensive disorders during pregnancy [Internet]. London: RCOG Press; 2010. [ cited 5 Mar 2015 ] Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=19. National Collaborating Centre for Women's and Children's Health (UK). Hypertension in pregnancy. The management of hypertensive disorders during pregnancy.

  20. Organización Panamericana de la salud. Normas y protocolos para la atención de las complicaciones obstétricas [Internet]. Washington: Organización Panamericana de la Salud; 2013. [ cited 24 Abr 2015 ] Available from: http://www.paho.org/nic/index.php?option=com_ docman&task=doc_details&gid=242&Itemid=23 5.

  21. World Health Organization. WHO recommendations for Prevention and treatment of pr e-eclampsia and eclampsia: evidence base [Internet]. Geneva: World Health Organization; 2011. [ cited 10 Feb 2015 ] Available from: http://apps.who.int/iris/handle/10665/70731.

  22. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008 ; 371 (9606): 75-84.

  23. Suppo LM, Bentlin MR, Petean CE. Preeclampsia: Effect on the Fetus and Newborn. NeoReviews [revista en Internet]. 2011 [ cited 3 Ene 2015 ] ; 12 (4): [aprox. 10p]. Available from: http://neoreviews.aappublications.org/content/12 /4/e198.abstract.

  24. Hansen AK, Wisborg K, Uldbjerg N, Henriksen TB. Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study. BMJ. 2008 ; 336 (7635): 85-7.

  25. Engle WA, Kominiarek MA. Late preterm infants, early term infants, and timing of elective deliveries. Clin Perinatol. 2008 ; 35 (2): 325-41.

  26. Ramachandrappa A, Jain L. Health issues of the late preterm infant. Pediatr Clin North Am. 2009 ; 56 (3): 565-77.

  27. Signore C, Klebanoff M. Neonatal morbidity and mortality after elective cesarean delivery. Clin Perinatol. 2008 ; 35 (2): 361-71.

  28. Faneite P, Rivera C, Faneite J, Amato R. Cesárea y mortalidad perinatal: incidencia y tendencia 42 años (1969-2010). Rev Obstet Ginecol Venez. 2012 ; 72 (3): 145-51.

  29. Barker PM, Olver RE. Invited review: Clearance of lung liquid during the perinatal period. J Appl Physiol (1985). 2002 ; 93 (4): 1542-8.

  30. Salihu HM. Epidemiology of stillbirth and fetal central nervous system injury. Semin Perinatol. 2008 ; 32 (4): 232-8.

  31. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012 ; 36 (1): 56-9.

  32. Chantler C. The second greatest benefit to mankind?. Clin Med. 2002 ; 2 (6): 544-53.

  33. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014 ; 2 (6): 323-33.




2020     |     www.medigraphic.com